Overview
Artificial Intelligence in medical diagnostics broadly refers to advanced algorithms and machine learning techniques used to analyze complex medical data for disease detection, diagnosis, and clinical decision-making. Given imaging, genomic, pathological, or EHR data, AI systems can swiftly and accurately sift through all such information. The systems thereby aid physicians in pattern detection, outcome prediction, and reduction of diagnostic errors. Radiology, pathology, dermatology, and ophthalmology are some of the fields where AI is increasingly deployed for earlier disease detection, enhanced workflows efficiencies, and to provide better patient outcomes through diagnostic insights that are both more accurate and personalized.

To learn more about this report, download the PDF brochure
Increasing volume of diagnostic bigdata to drive market growth
The increasing volume of diagnostic big data is a key factor impacting the growth of the medical diagnostics AI market. Healthcare facilities generate large amounts of data daily from imaging (like MRI and CT), pathology slides, genomics, and EHRs among others. Manual analysis of these datasets is laborious and can introduce errors. AI algorithms can process big data relatively quickly, and process enormous amounts of complex data and ultimately produce information that can lead to valid, timely and accurate diagnoses. This leads to earlier disease detection, improved clinical decision-making, and increased efficiency. As diagnostic data volumes increase, it is likely that the demand for AI tools that can manage, interpret, and extract value from these data rise.
Collaborations between tech companies and healthcare providers - A key market trend
Collaborations between tech companies and healthcare providers is a key trend contributing to growth in the AI in medical diagnostics market. These partnerships bring together the technical skills and development experience of the technology firm and the clinical expertise of the healthcare provider, allowing to develop, validate, and imAI-enabled diagnostic tools faster. For instance, in January 2025, GE healthcare entered into a medical imaging AI deal worth more than USD 249 million with Nuffield Health, a healthcare charity operating 36 hospitals in the UK. Similarly in June 2024, Qure.ai entered into a partnership with Strategic Radiology, a coalition of independently owned and operated local private radiology practices, with a view to advance clinical accuracy and operational efficiency through access to advanced medical imaging AI technology. Such collaborations present value in a few different ways, including accelerating innovation, enhancing algorithm accuracy through access to real-world data, and improving clinical integration.

To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global artificial intelligence (AI) in medical diagnostics market is marked by the presence of established and emerging market players such as Microsoft; Nvidia Corporation; Merative; Google (Alphabet Inc.); Siemens Healthineers AG; GE Healthcare; Intel Corporation; InformAI; Digital Diagnostics Inc.; and Enlitic Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | ~22% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | By Component, Modality, Application, End User |
| Regional Scope |
|
| Key Companies Mapped | Microsoft; Nvidia Corporation; Merative; Google (Alphabet Inc.); Siemens Healthineers AG; GE Healthcare; Intel Corporation; InformAI; Digital Diagnostics Inc.; and Enlitic Inc. among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Artificial Intelligence (AI) in Medical Diagnostics Market Segmentation
This report by Medi-Tech Insights provides thesize of the global artificial intelligence (AI) in medical diagnostics market at theregional- and country-level from 2023 to 2030. The report further segments the market based on component, modality, application, and end user.
Market Size & Forecast (2023-2030), By Component, USD Million
- Software
- Services
- Hardware
Market Size & Forecast (2023-2030), By Modality, USD Million
- Imaging Modalities
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- X-Ray
- Ultrasound
- Others Imaging Modalities
- Diagnostic Modalities
Market Size & Forecast (2023-2030), By Applllion
- Radiology/General Imaging
- Oncology
- Cardiology
- Neurology
- Obstetrics and Gynaecology
- Ophthalmology
- Immunology
- Infectious Diseases
- Others
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals
- Diagnostic Imaging Centers
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the artificial intelligence (AI) in medical diagnostics market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the artificial intelligence (AI) in medical diagnostics market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.